Clinical Trial Update: The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for atropine 0.01% in the prevention and control of myopia; trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine 0.01% (atropine)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Myopia | Phase 3 | Status: ACTIVE_NOT_RECRUITING